Herspiegel Consulting Dives Into the Value Narrative
Kapil Raina, MD, Principal of Market Access at Herspiegel Consulting, talks about disconnects in the industry, how patients have easier access to healthcare information, and the exciting future of pharmaceutical manufacturing and patient care.
The demand to balance product value, cost, and effectiveness can create bottlenecks for pharmaceutical manufacturers. Herspiegel Consulting works with clients ranging from startups to mid-size and large pharma companies to address this challenge through a “value narrative,” which covers strategic approaches that use data-driven insights to improve affordability, accessibility, and availability of care for patients. In this video, Kapil Raina, MD, Principal of Market Access at Herspiegel Consulting, stresses the growing importance of clear communication with patients, especially as they gain greater access to healthcare information.
Key Learning Objectives
- Understand key trends within market access that impact the value of therapies.
- Learn about disconnects in pharmaceutical manufacturing in the value journey.
- Learn how patients should be receiving their prescription drugs within shorter timelines, highlighting an industry gap.
Asembia 2025: Therapy Advancements Highlight Growing Cost and Access Concerns
April 30th 2025Fran Gregory, VP, emerging therapies, Cardinal Health, discusses the evolving cell and gene therapy landscape, highlighting pipeline growth, cost challenges, and emerging therapeutic areas beyond oncology and hematology.
